No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs535427885 |
chr15:31391227-31391228 |
Enhancers Weak transcription Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs181740793 |
chr15:31391261-31391262 |
Enhancers Weak transcription Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs550842728 |
chr15:31391268-31391269 |
Enhancers Weak transcription Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs139443330 |
chr15:31391279-31391280 |
Enhancers Weak transcription Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs149671533 |
chr15:31391282-31391283 |
Enhancers Weak transcription Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs553112500 |
chr15:31391283-31391284 |
Enhancers Weak transcription Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs573198101 |
chr15:31391285-31391286 |
Enhancers Weak transcription Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs146864074 |
chr15:31391344-31391345 |
Enhancers Weak transcription Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs555410322 |
chr15:31391449-31391450 |
Enhancers Bivalent Enhancer Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs575262143 |
chr15:31391467-31391468 |
Enhancers Bivalent Enhancer Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs544189569 |
chr15:31391471-31391472 |
Enhancers Bivalent Enhancer Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs186820111 |
chr15:31391491-31391492 |
Enhancers Bivalent Enhancer Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs577651714 |
chr15:31391513-31391514 |
Enhancers Bivalent Enhancer Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs543728203 |
chr15:31391606-31391607 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs546107670 |
chr15:31391613-31391614 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs559492190 |
chr15:31391684-31391685 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs34449068 |
chr15:31391692-31391693 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs528770431 |
chr15:31391748-31391749 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs550430968 |
chr15:31391886-31391887 |
Enhancers Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs571629265 |
chr15:31391944-31391945 |
Enhancers Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs548429436 |
chr15:31391953-31391954 |
Enhancers Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs562041321 |
chr15:31391962-31391963 |
Enhancers Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs530855212 |
chr15:31392069-31392070 |
Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs192024645 |
chr15:31392140-31392141 |
Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs11070810 |
chr15:31392141-31392142 |
Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
26 |
rs539895933 |
chr15:31392160-31392161 |
Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs75995060 |
chr15:31392164-31392165 |
Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs529465675 |
chr15:31392203-31392204 |
Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs183153495 |
chr15:31392228-31392229 |
Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs74349507 |
chr15:31392301-31392302 |
Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs535749415 |
chr15:31392321-31392322 |
Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs555742691 |
chr15:31392331-31392332 |
Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs575598125 |
chr15:31392347-31392348 |
Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs537477409 |
chr15:31392359-31392360 |
Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs10851488 |
chr15:31392375-31392376 |
Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
36 |
rs577685421 |
chr15:31392376-31392377 |
Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs112033309 |
chr15:31392405-31392406 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs111483758 |
chr15:31392425-31392426 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs375802051 |
chr15:31392426-31392427 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs10851489 |
chr15:31392436-31392437 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs562081825 |
chr15:31392466-31392467 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs531217090 |
chr15:31392480-31392481 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs544303808 |
chr15:31392525-31392526 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs146605543 |
chr15:31392568-31392569 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs533273866 |
chr15:31392677-31392678 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs547066913 |
chr15:31392703-31392704 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs566964790 |
chr15:31392705-31392706 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs529140302 |
chr15:31392707-31392708 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs117836080 |
chr15:31392723-31392724 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs569203374 |
chr15:31392791-31392792 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|